Akso Health (AHG) F-3 Shelf registration (foreign)

Exhibit 107

Calculation of Filing Fee Tables

F-3
(Form Type)

AKSO HEALTH GROUP

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title(5)

Fee Calculation or Carry Forward Rule

Amount Registered(1)

Proposed Maximum Offering Price Per Unit(2)

Maximum Aggregate Offering Price(3)

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to be paid

Equity

Ordinary Shares, $0.0001 par value per share

Rule 457(o)

Equity

Ordinary Shares represented by American Depositary Shares

Equity

Debt Securities

Equity

Warrants

Equity

Rights

Equity

Units

$

350,000,000

0.00014760

$

51,660

Carry Forward Securities

Carry forward Securities

Equity

Ordinary Shares, $0.0001 par value per share

Equity

Ordinary Shares represented by American Depositary Shares

Equity

Warrants

Carry Forward Securities

Unallocated (Universal) Shelf

Unallocated (Universal) Shelf

Rule 415(a) (6)

$

50,000,000

F-3

333-252434

02/25/2021

$

5,455

Total Offering Amounts

$

400,000,000

$

59,040

Total Fees Previously Paid

$

5,455

Total Fee Offsets(4)

$

5,455

Net Fee Due

$

53,585

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (or the Securities Act), an indeterminate number of additional securities are registered hereunder that may be issued to prevent dilution in connection with a stock split, stock dividend, recapitalization, or similar event or adjustment. In addition, an indeterminate number of common shares are registered hereunder that may be issued upon conversion of or exchange for any other securities.

(2) There are being registered hereunder such indeterminate number of the securities of each identified class being registered as may be sold from time to time at indeterminate prices, with an initial aggregate public offering price not to exceed $400,000,000. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities or that are issued in units. To the extent that separate consideration is received for any such securities, the aggregate amount of such consideration will be included in the aggregate offering price of all securities sold. If any debt securities are issued at an original issue discount, then the offering may be in such greater principal amount as shall result in a maximum aggregate offering price not to exceed $400,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as part of units, which may consist of any combination of the securities registered hereunder.

(3) Pursuant to Instructions to the Calculation of Filing Fee Tables and Related Disclosure of Form F-3, the table does not specify by each class information as to the proposed maximum aggregate offering price. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder.

(4) The Registrant previously filed a Registration Statement on Form F-3 with the Securities and Exchange Commission on January 26, 2021 (File No. 333-252434), which was declared effective on February 25, 2021 (the “Prior Registration Statement”), that registered an aggregate of $50,000,000 of an indeterminate number of securities to be offered by the Registrant from time to time. Of the $50,000,000 of securities registered on the Prior Registration Statement, for which the Registrant paid a filing fee of $5,455. In connection therewith, $50,000,000 of the securities remain unsold, leaving $5,455 in previously paid fees available for future offset (calculated at the fee rate in effect on the filing date of the Prior Registration Statement). In accordance with Rule 457(p) under the Securities Act, the Registrant is using $5,455 of the unused filing fees to offset the filing fee payable in connection with this filing. Accordingly, a registration fee of $53,585 is due to be paid at this time. Concurrently with the effectiveness of this registration statement, any offering of unsold securities pursuant to the Prior Registration Statement is hereby terminated.

(5) Represented by American depositary shares, or ADSs. The ADSs issuable upon deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (File No. 333-220966), as amended. Each ADS represents three ordinary shares.

2

Table 2: Fee Offset Claims and Sources

Registrant or Filer Name

Form or Filing Type

File Number

Initial Filing Date

Filing Date

Fee Offset Claimed

Security Type Associated with Fee Offset Claimed

Security Title Associated with Fee Offset Claimed (1)

Unsold Securities Associated with Fee Offset Claimed

Unsold Aggregate Offering Amount Associated with Fee Offset Claimed

Fee Paid with Fee Offset Source

Rules 457(b) and 0-11(a)(2)

Fee Offset Claims

Fee Offset Sources

Rule 457(p)

Fee Offset Claims

AKSO HEALTH GROUP

F-3

333-252434

01/26/2021

$

5,455

Unallocated (Universal) Shelf

(1)

Unallocated (Universal) Shelf

$50,000,000.

Fee Offset Sources

AKSO HEALTH GROUP

F-3

333-252434

01/26/2021

$

5455

(1) Pursuant to Rule 457(p) under the Securities Act, the Registrant is offsetting the registration fee due under this registration statement by $5,455, which represents the portion of the registration fee previously paid (after offset) with respect to $50,000,000 of unsold securities (the “Unsold Offset Securities”) previously registered on the Prior Registration Statement. The offering of the Unsold Offset Securities pursuant to the Prior Registration Statement associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated.

3